Advertisement
Advertisement
U.S. markets open in 1 hour 42 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.1500-0.0200 (-1.71%)
At close: 04:00PM EDT
1.1600 +0.01 (+0.87%)
Pre-Market: 05:40AM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/28/2023
Current
6/30/20233/31/202312/31/20229/30/20226/30/2022
Market Cap (intraday)
216.56M172.14M104.14M106.15M58.17M64.87M
Enterprise Value
221.71M198.06M113.46M62.28M48.59M25.50M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
1.060.630.350.350.190.27
Price/Book (mrq)
N/AN/A11.157.670.932.48
Enterprise Value/Revenue
1.103.512.831.130.990.20
Enterprise Value/EBITDA
-6.09-21.79-4.57-12.14-1.260.58

Trading Information

Stock Price History

Beta (5Y Monthly) 0.82
52-Week Change 3283.33%
S&P500 52-Week Change 317.42%
52 Week High 31.8400
52 Week Low 30.2410
50-Day Moving Average 31.3396
200-Day Moving Average 30.9616

Share Statistics

Avg Vol (3 month) 31.74M
Avg Vol (10 day) 31.05M
Shares Outstanding 5188.31M
Implied Shares Outstanding 6191.59M
Float 8167.26M
% Held by Insiders 11.69%
% Held by Institutions 128.72%
Shares Short (Sep 14, 2023) 47.23M
Short Ratio (Sep 14, 2023) 44.98
Short % of Float (Sep 14, 2023) 43.88%
Short % of Shares Outstanding (Sep 14, 2023) 43.84%
Shares Short (prior month Aug 14, 2023) 46.76M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Jun 29, 2023

Profitability

Profit Margin -48.90%
Operating Margin (ttm)-28.97%

Management Effectiveness

Return on Assets (ttm)-9.38%
Return on Equity (ttm)-553.45%

Income Statement

Revenue (ttm)200.88M
Revenue Per Share (ttm)1.09
Quarterly Revenue Growth (yoy)-55.40%
Gross Profit (ttm)140.04M
EBITDA -20.54M
Net Income Avi to Common (ttm)-98.22M
Diluted EPS (ttm)-0.5100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)53.57M
Total Cash Per Share (mrq)0.28
Total Debt (mrq)58.72M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.28
Book Value Per Share (mrq)-0.14

Cash Flow Statement

Operating Cash Flow (ttm)-34.78M
Levered Free Cash Flow (ttm)35.89M
Advertisement
Advertisement